Abstract:Peptide-based medications hold immense potential in addressing a wide range of human disorders and discomforts. However, their widespread utilization encounters two major challenges: preservation and production efficiency. Cyclotides, a class of ribosomally synthesized and post-translationally modified peptides (RiPPs), exhibit unique characteristics, such as a cyclic backbone and cystine knot, enhancing their stability and contributing to a wide range of pharmacological properties exhibited by these compounds. Cyclotides are efficient in the biomedical (e.g., antitumor, antidiabetic, antimicrobial, antiviral) and agrochemical fields by exhibiting activity against pests and plant diseases. Furthermore, their structural attributes make them suitable as molecular scaffolds for grafting and drug delivery. Notably, the mutated variant of kalata B1 cyclotide ([T20K] kalata B1) has recently entered phase 1 of human clinical trials for multiple sclerosis, building upon the success observed in animal trials. To enable large-scale production of cyclotides, it is crucial to further explore their remarkable structural and bioactive properties. This necessitates extensive research focused on enhancing the efficiency of the processes required for their production. This study provides a comprehensive review of the biological synthesis methods of cyclotides, with particular emphasis on various expression systems, namely bacteria, plants, yeast, and cell-free systems. By investigating these expression systems, it becomes possible to design production systems that are adaptable, economically viable, and efficient for generating active and pure cyclotides at an industrial scale. The advantages of biological synthesis over chemical synthesis are thoroughly explored, highlighting the potential of these expression systems in meeting the demands of large-scale cyclotide production.

Synthesis and Characterization of Kalata B2 Cyclotide (GLPVCGETCFGGTCNTPGCSCTWPICTRD) on Wang Resin, as Solid Support

Synthesis and Characterization of Altaicadispirolactone

Analysis of the Structural Stability Among Cyclotide Members Through Cystine Knot Fold that Underpins Its Potential Use as a Drug Scaffold

Improved method for quantitative analysis of the cyclotide kalata B1 in plasma and brain homogenate

Cellular Uptake and Cytosolic Delivery of a Cyclic Cystine Knot Scaffold

Scanning mutagenesis identifies residues that improve the long-term stability and insecticidal activity of cyclotide kalata B1

The N‐terminal pro‐domain of the kalata B1 cyclotide precursor is intrinsically unstructured

Papain-like cysteine proteases prepare plant cyclic peptide precursors for cyclization

Dynamic Scenario of Membrane Binding Process of Kalata B1

Production of a structurally validated cyclotide in rice suspension cells is enabled by a supporting biosynthetic enzyme

Enhancing cyclotide bioproduction: harnessing biological synthesis methods and various expression systems for large-scale manufacturing

Convergent Total Synthesis of Kalmanol

Exploring the Limits of Cyanobactin Macrocyclase PatGmac: Cyclization of PawS-Derived Peptide Sunflower Trypsin Inhibitor-1 and Cyclotide Kalata B1

Total Synthesis of Wewakazole B

Synthesis and Late-Stage Modification of (−)-Doliculide Derivatives Using Matteson's Homologation Approach

Synthesis and Characterization of Hexakis (2-(2-oxo-1-pyrrolidinyl) Cyclotriphosphazene)

Cyclotides derived from Viola dalatensis Gagnep: A novel approach for enrichment and evaluation of antimicrobial activity

Chemical Synthesis of a Cyclotide Via Intramolecular Cyclization of Peptide O-esters

Cyclotides, a Novel Ultrastable Polypeptide Scaffold for Drug Discovery

Proximity Labelling Confirms the Involvement of Papain-Like Cysteine Proteases and Chaperones in Cyclotide Biosynthesis

Total Synthesis of Cyclosenegalin A